| Khasraw M, Pavlakis N, McCowatt S, et al.
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Petrausch U, Samaras P, Veit-Haibach P, et al.
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Paiva CE, Drigo SA, Rosa FE, et al.
Absence of transforming growth factor-{beta} type II receptor is associated with poorer prognosis in HER2-negative breast tumours. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Glimelius B, Spindler KL, Frödin JE, et al.
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Full Citation | Publisher Full Text | Find Related Articles | | Xie P, Yue JB, Fu Z, et al.
Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Camerini A, Valsuani C, Mazzoni F, et al.
Phase II trial of single-agent oral vinorelbine in elderly (>=70 years) patients with advanced non-small-cell lung cancer and poor performance status. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ghesquières H, Ferlay C, Sebban C, et al.
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mavroudis D, Papakotoulas P, Ardavanis A, et al.
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pecorelli S, Ray-Coquard I, Tredan O, et al.
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Aragon-Ching JB, Dahut WL
About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here? [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 10.
Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
